Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex

Bulletin of Experimental Biology and Medicine

Volumn 142, Issue 6, 2006, Pages 663-666

  Romanova, G A ^c   Silachev, D N ^a   Shakova, F M ^c   Kvashennikova, Y N ^c   Viktorov, I V ^b   Shram, S I ^a   Myasoedov, N F ^c  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^b V P Serbskii State Research Center of Social and Forensic Psychiatry   (Russian Federation)

^c INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

Amnesia; Experimental ischemic infarction of the cerebral cortex; Neuroprotection; Photoinduced thrombosis; Semax

Indexed keywords

METHIONYLGLUTAMYLHISTIDINYLPHENYLALANYLPROLYLGLYCYLPROLINE; NOOTROPIC AGENT; PLACEBO; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; LATENT PERIOD; LOCOMOTION; MALE; MEMORY CONSOLIDATION; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PREFRONTAL CORTEX; RAT;

ADMINISTRATION, INTRANASAL; ADRENOCORTICOTROPIC HORMONE; AMNESIA; ANIMALS; ANIMALS, OUTBRED STRAINS; BRAIN INFARCTION; CEREBRAL CORTEX; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; TREATMENT OUTCOME;

EID: 34147157954     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0445-0     Document Type: Article

References (14)

1. I. P. Ashmarin, V. N. Nezavibatko, N. F. Myasoedov, et al., Zh. Vyssh. Nervn. Deyat., 47, No. 2, 420-430 (1997).
2. Ya. Buresh, O. Bureshova, and J. P. Houston, Methods and Main Experiments for Studies of the Brain and Behavior [in Russian], Moscow (1991).
3. I. A. Grivennikov, O. V. Dolotov, Yu. I. Gol'dina, et al., Mol. Biol., 33, No. 1, 120-126 (1999).
4. E. I. Gusev and V. I. Skvortsova, Cerebral Ischemia [in Russian], Moscow (2001).
5. O. V. Dolotov, T. S. Seredenina, N. G. Levitskaya, et al., Dokl. Ros. Akad. Nauk, 91, 292-295 (2003).
6. N. F. Myasoedov, V. I. Skvortsova, E. L. Nasonov, et al., Zh. Nevrol. Psikhiatr., No. 5, 15-31 (1999).
7. G. A. Romanova, Dysregulation Changes in Integrative Function of the Brain during Focal Cerebral Ischemia. Dysregulation Pathology [in Russian], Moscow (2002), pp. 605-615.
8. E. R. Safarova, S. I. Shram, Yu. A. Zolotarev, and N. F. Myasoedov, Byull. Eksp. Biol. Med., 136, No. 3, 309-313 (2003).
9. E. V. Yakovleva, V. S. Kuzenkov, V. N. Fedorov, et al., Ibid., 128, No. 3, 172-174 (1999).
10. I. P. Ashmarin, V. N. Nezavibatko, N. G. Levitskaya, et al., Neurosci. Res. Commun., 16, No. 2, 105-112 (1995).
11. V. G. Bashkatova, V. B. Koshelev, O. E. Fadyukova, et al., Brain Res., 894, No. 1, 145-149 (2001).
12. N. G. Levitskaya, E. A. Sebentsova, L. A. Andreeva, et al., Neurosci. Behav. Physiol., 34, No. 4, 399-405 (2004).
13. R. U. Ostrovskaya, G. A. Romanova, I. V. Barskov, et al., Behav. Pharmacol., 10, No. 5, 549-553 (1999).
14. B. D. Watson, W. D. Dietrich, R. Busto, et al., Ann. Neurol., 17, No. 5, 497-504 (1985).